Invivyd, Inc. — Director's Dealing 2022

Dec 6, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Invivyd, Inc. (IVVD)
CIK: 0001832038
Period of Report: 2022-12-06

Reporting Person: Schmidt Peter (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6971	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.61	2031-01-12	Common Stock (112900)		Direct
Stock Option (Right to Buy)	$6.39	2032-02-13	Common Stock (73800)		Direct

Footnotes

F1: This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of January 13, 2021, and 1/48th of the total shares subject to the option vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date.

F2: This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of February 14, 2022, subject to the Reporting Person's continuous service as of each vesting date.